Monopar Therapeutics (MNPR) Other Working Capital Changes: 2016-2024
Historic Other Working Capital Changes for Monopar Therapeutics (MNPR) over the last 9 years, with Dec 2024 value amounting to $21,792.
- Monopar Therapeutics' Other Working Capital Changes rose 926.24% to $76,609 in Q3 2020 from the same period last year, while for Sep 2020 it was -$59,419, marking a year-over-year increase of 46.80%. This contributed to the annual value of $21,792 for FY2024, which is 6.77% up from last year.
- Latest data reveals that Monopar Therapeutics reported Other Working Capital Changes of $21,792 as of FY2024, which was up 6.77% from $20,410 recorded in FY2023.
- In the past 5 years, Monopar Therapeutics' Other Working Capital Changes registered a high of $21,792 during FY2024, and its lowest value of -$171,755 during FY2022.
- In the last 3 years, Monopar Therapeutics' Other Working Capital Changes had a median value of $20,410 in 2023 and averaged -$43,184.
- As far as peak fluctuations go, Monopar Therapeutics' Other Working Capital Changes spiked by 141.46% in 2020, and later slumped by 2,374.95% in 2021.
- Monopar Therapeutics' Other Working Capital Changes (Yearly) stood at $3,789 in 2020, then slumped by 2,374.95% to -$86,198 in 2021, then tumbled by 99.26% to -$171,755 in 2022, then soared by 111.88% to $20,410 in 2023, then increased by 6.77% to $21,792 in 2024.